- Lobbying
- Lobbying by Satellite Healthcare
Lobbying Relationship
Bills mentioned
S.1676: Chronic Kidney Disease Improvement in Research and Treatment Act of 2019
Sponsor: Benjamin L. Cardin (D-Md.)
H.R.3912: Chronic Kidney Disease Improvement in Research and Treatment Act
Sponsor: John Lewis (D-Ga.)
H.R.5534: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant...
Sponsor: Ron Kind (D-Wis.)
H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Sponsor: Nita M. Lowey (D-N.Y.)
H.R.6201: Families First Coronavirus Response Act
Sponsor: Nita M. Lowey (D-N.Y.)
H.R.748: CARES Act
Sponsor: Joe Courtney (D-Conn.)
H.R.6800: The Heroes Act
Sponsor: Nita M. Lowey (D-N.Y.)
H.R.1319: American Rescue Plan Act of 2021
Sponsor: John Yarmuth (D-Ky.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Geoff Werth | Rep. Bart Stupak, Senior Legislative Assistant; Minority Leader Dick Gephardt, Policy Advisor |
Billy Wynne | Health Policy Counsel, Senate Finance Committee |
Katie Pahner | Health Insurance Specialist, Ctrs. for Medicare/Medicaid Svc |
Alyson Lewis | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate